Literature DB >> 20632051

Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.

C Ilchmann1, N H Zaiss, A Speicher, M Christner, G Ackermann, H Rohde.   

Abstract

Worldwide increasing rates of Clostridium difficile infections (CDI) with severe courses and outbreaks have been reported. This change in CDI epidemiology has on one hand been related to the spread of specific PCR ribotypes (e.g. 027) and on the other hand to increased prevalence of resistant C. difficile strains. This single-centre retrospective analysis characterized resistance against erythromycin and moxifloxacin, presence of binary toxin gene and ribotypes in 73 C. difficile isolates from 2008 in comparison with 23 isolates from 1990. In 1990, five different PCR ribotypes including 027 were identified. Resistance against erythromycin was detected in 3 of 23 (13%), while 20 of 23 (87%) from all isolates were susceptible to both erythromycin and moxifloxacin. In contrast, in 2008 a significantly increased prevalence of resistant C. difficile strains was observed, with 40 of 73 (54.8%) isolates being resistant against both antibiotics. Resistant C. difficile strains were mainly assigned to PCR ribotype 001. No isolates belonging to PCR ribotype 027 were identified. Our data provide evidence that the increase of resistant C. difficile strains belonging to PCR ribotype 001 rather than the spread of C. difficile PCR ribotype 027 contribute to the changing epidemiology of CDI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632051     DOI: 10.1007/s10096-010-1017-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  Clostridium difficile toxinotype V, ribotype 078, in animals and humans.

Authors:  Maja Rupnik; Andreas Widmer; Ortrud Zimmermann; Catherine Eckert; Frédéric Barbut
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

3.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Authors:  P Bidet; F Barbut; V Lalande; B Burghoffer; J C Petit
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

Review 4.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

5.  Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.

Authors:  M Arvand; A M Hauri; N H Zaiss; W Witte; G Bettge-Weller
Journal:  Euro Surveill       Date:  2009-11-12

6.  Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Authors:  S Borgmann; M Kist; T Jakobiak; M Reil; E Scholz; C von Eichel-Streiber; H Gruber; J S Brazier; B Schulte
Journal:  Euro Surveill       Date:  2008-12-04

7.  Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.

Authors:  F Barbut; P Mastrantonio; M Delmée; J Brazier; E Kuijper; I Poxton
Journal:  Clin Microbiol Infect       Date:  2007-09-11       Impact factor: 8.067

8.  Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains.

Authors:  Warren N Fawley; Sarah Underwood; Jane Freeman; Simon D Baines; Katie Saxton; Keith Stephenson; Robert C Owens; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-15       Impact factor: 3.254

Review 9.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

10.  Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

Authors:  Robert Gaynes; David Rimland; Edna Killum; H Ken Lowery; Theodore M Johnson; George Killgore; Fred C Tenover
Journal:  Clin Infect Dis       Date:  2004-02-11       Impact factor: 9.079

View more
  3 in total

1.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

Review 2.  The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis.

Authors:  Chenjie Tang; Lunbiao Cui; Yuqiao Xu; Le Xie; Pengfei Sun; Chengcheng Liu; Wenying Xia; Genyan Liu
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

Review 3.  Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.

Authors:  Simon D Baines; Mark H Wilcox
Journal:  Antibiotics (Basel)       Date:  2015-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.